I have reread that article I posted and cannot see where it mentions "wet" macular degeneration. I do not have foreknowledge of these drugs or in particular Avastin's cancer drug being used for "wet" macular degeneration and if that is the case my apoligies.
At any rate I like the idea that ACTC will have an opportunity render these drugs obsolete and in a 25-30 billion dollar market.